JACC Journals
Aug 24, 2026, 16:38
PCSK9i Is a Powerful Lipid-Lowering Strategy – But Is It Also Anti-Inflammatory?- JACC Journals
JACC Journals shared a post on X about a recent article by Deng Bing-yan et al., published in JACC: Asia, adding:
“PCSK9i is a powerful lipid-lowering strategy – but is it also anti-inflammatory?
JACC: Asia review distinguishes mechanistic signals from proven human effects, showing plaque stabilization, immune pathways and limits of conventional inflammatory biomarkers.”
Title: The Impact of PCSK9 Inhibitors on Circulatory Inflammation: Mechanisms, Evidence, and Application Prospects
Authors: Deng Bing-yan, Wang Jing-ya, Yuan Yu-juan, Dong Xiang-yu, Lai Hong-mei, Peng Hui, Yang Yi-ning, Yu Xiao-lin
Stay updated on the latest scientific advances with Hemostasis Today.
-
Oct 8, 2026, 04:28Jeff Molter: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 04:23Barbara Adams Krolak: Women and Blood Clots Are We Missing the Warning Signs
-
Oct 8, 2026, 04:10Rutendo Muzambi: Hospital Admission Patterns and Care Disparities in Sickle Cell Disease
-
Oct 8, 2026, 03:50Olfat Berro: Redefining the Future of Haemophilia A
-
Oct 8, 2026, 03:35Tasnia Tarana: Heavy Menstrual Bleeding When the Cause Is Not in the Uterus
-
Oct 8, 2026, 03:28Kian Haseli: Electrophysiological PIEZO1 Analysis Advances Diagnosis in Hereditary Xerocytosis
-
Oct 8, 2026, 03:20Sthanu Subramanian: Leukopenia in Sepsis A Marker of Severe Disease
-
Oct 7, 2026, 16:44Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
-
Oct 7, 2026, 16:04NETs in Thrombosis: From Mechanism to Therapeutic Target